Transactivation_NN
of_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
promoter_NN
by_IN
human_JJ
herpesvirus_NN
6_CD
-LRB-_-LRB-
HHV-6_NN
-RRB-_-RRB-
strains_NN
GS_NN
and_CC
Z-29_NN
in_IN
primary_JJ
human_JJ
T_NN
lymphocytes_NNS
and_CC
identification_NN
of_IN
transactivating_JJ
HHV-6_NN
-LRB-_-LRB-
GS_NN
-RRB-_-RRB-
gene_NN
fragments_NNS
._.

Human_JJ
herpesvirus_NN
6_CD
-LRB-_-LRB-
HHV-6_NN
-RRB-_-RRB-
can_MD
activate_VB
the_DT
human_JJ
immunodeficiency_NN
virus_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
promoter_NN
and_CC
accelerate_VB
cytopathic_JJ
effects_NNS
in_IN
HIV-infected_JJ
human_JJ
T_NN
cells_NNS
._.

This_DT
study_NN
examines_VBZ
the_DT
regions_NNS
of_IN
the_DT
HIV_NN
promoter_NN
required_VBN
for_IN
HHV-6_NN
transactivation_NN
in_IN
a_DT
heterogeneous_JJ
population_NN
of_IN
primary_JJ
human_JJ
T_NN
lymphocytes_NNS
with_IN
or_CC
without_IN
antigenic_JJ
stimulation_NN
._.

Two_CD
different_JJ
strains_NNS
of_IN
HHV-6_NN
,_,
GS_NN
and_CC
Z29_NN
,_,
transactivated_VBD
the_DT
HIV_NN
promoter_NN
._.

The_DT
GS_NN
strain_NN
transactivated_VBD
the_DT
promoter_NN
in_IN
both_CC
stimulated_VBN
and_CC
resting_VBG
T_NN
cells_NNS
,_,
while_IN
the_DT
Z29_NN
strain_NN
increased_VBD
HIV_NN
promoter_NN
activity_NN
only_RB
in_IN
stimulated_VBN
T_NN
cells_NNS
._.

Three_CD
DNA_NN
clones_NNS
containing_VBG
HHV-6_NN
-LRB-_-LRB-
GS_NN
-RRB-_-RRB-
genomic_JJ
fragments_NNS
transactivated_VBD
the_DT
HIV_NN
promoter_NN
in_IN
cotransfected_VBN
T_NN
cells_NNS
._.

A_DT
21.4-kb_JJ
DNA_NN
clone_NN
,_,
pZVB70_NN
,_,
showed_VBD
the_DT
highest_JJS
transactivating_VBG
ability_NN
,_,
while_IN
two_CD
other_JJ
DNA_NN
fragments_NNS
,_,
pZVB10_NN
-LRB-_-LRB-
6.2_CD
kb_NN
-RRB-_-RRB-
and_CC
pZVH14_NN
-LRB-_-LRB-
8.7_CD
kb_NN
-RRB-_-RRB-
,_,
showed_VBD
lower_JJR
activity_NN
._.

One_CD
of_IN
these_DT
clones_NNS
,_,
pZVH14_NN
,_,
activated_VBD
the_DT
HIV_NN
promoter_NN
construct_NN
containing_VBG
a_DT
mutation_NN
in_IN
the_DT
NF_NN
kappa_NN
B_NN
site_NN
._.

However_RB
,_,
this_DT
mutated_VBN
NF_NN
kappa_NN
B_NN
promoter_NN
was_VBD
not_RB
transactivated_VBN
during_IN
HHV-6_NN
-LRB-_-LRB-
GS_NN
-RRB-_-RRB-
infection_NN
or_CC
after_IN
cotransfection_NN
with_IN
pZVB70_NN
or_CC
pZVB10_NN
._.

These_DT
data_NNS
indicate_VBP
that_IN
the_DT
NF_NN
kappa_NN
B_NN
sites_NNS
of_IN
the_DT
HIV_NN
promoter_NN
are_VBP
essential_JJ
for_IN
its_PRP$
transactivation_NN
during_IN
HHV-6_NN
-LRB-_-LRB-
GS_NN
-RRB-_-RRB-
infection_NN
._.

By_IN
increasing_VBG
HIV_NN
promoter_NN
activity_NN
in_IN
primary_JJ
T_NN
lymphocytes_NNS
,_,
HHV-6_NN
may_MD
consequently_RB
increase_VB
HIV_NN
replication_NN
,_,
leading_VBG
to_TO
an_DT
increase_NN
in_IN
the_DT
cytopathic_JJ
effect_NN
on_IN
coinfected_VBN
human_JJ
T_NN
cells_NNS
._.

